BRAF and AXL oncogenes drive RIPK3 expression loss in cancer
Fig 5
Role of oncogenes in the escape from necroptosis in cancer.
Oncogenic BRAF (e.g., V600E mutation), AXL overexpression, and other oncogenic factors may promote escape from necroptosis via suppression of RIPK3 expression during tumorigenesis.